The first receipts of the Johnson & Johnson vaccine against COVID-19 after the approval it received are expected to begin tomorrow, Tuesday, helping to increase vaccination rates in the US, as announced yesterday, Sunday, high-ranking US government officials.
Officials acknowledged that vaccination rates among minorities “are not where we would like them to be.”
The same officials are urging everyone in the US to get vaccinated as soon as it is their turn.
Source: ΑΠΕ-ΜΠΕ
FDA: Johnson & Johnson vaccine license in the US
Belgium: Clinical trials of Chinese vaccine are expected to begin
Source: politis.com.cy
